TOKYO -- In spring 2020, as the COVID-19 pandemic took hold, many pharmaceutical companies faced supply chain disruptions. Often, chemicals used to produce the key ingredients in drugs were sourced from only a few suppliers in China -- or sometimes just one.
Pharmaceuticals
The great medicines migration: How China controls key drug supplies
Western powers aim to reverse the industry's West-to-East shift
By the pandemic year of 2020, China accounted for the bulk of exports of certain pharmaceutical raw materials. The country now plays an indispensable role in the supply chain for antibiotics and vitamins.
Read Next
Latest on Pharmaceuticals
